Why the study?
Little is known about multisample iohexol mGFR protocols when GFR is not decreased, motivating research into shorter protocols with earlier sampling times to improve efficiency.
Do shorter iohexol GFR measurement protocols provide accurate and precise results compared to the reference standard in individuals with preserved kidney function?
Do shorter iohexol GFR measurement protocols provide accurate and precise results compared to the reference standard in individuals with preserved kidney function?
Shorter iohexol GFR measurement protocols provide similar accuracy to the standard 240-minute protocol in patients with preserved kidney function, allowing for significantly decreased procedure time.
Answers are grounded in this paper and cite their sources.
May enable shorter, lower-cost mGFR testing in preserved-GFR settings; extends KDIGO research priorities but leaves open broader validation.
Key Points Shorter measured GFR protocols are accurate and precise compared with the reference standard measured GFR protocol in patients with preserved GFR. These shorter protocols can potentially improve the adoption of GFR measurement more widely by reducing procedural time and cost. Background Measured GFR (mGFR) using exogenous tracers is recommended in a number of settings. Plasma one-compartment multisample protocols (MSPs) are the most commonly used, with iohexol being the dominant tracer. The accuracy of MSPs has mostly been evaluated in the setting of reduced GFR where delayed initial and final samples are recommended. Much less is known about MSPs when GFR is not decreased, and the default protocol tends to include initial sampling at 120 minutes and final sampling at 240 minutes after iohexol injection. The recent Kidney Disease Improving Global Outcomes 2024 Clinical Practice Guideline for the Evaluation and Management of CKD includes research recommendations for the development of shorter more efficient mGFR protocols. The objective of this study was to assess the performance of shorter MSPs with earlier initial (60 and 90 minutes) and final (150, 180, and 210 minutes) sampling times in individuals with preserved GFR. Reference mGFR (R-mGFR) was calculated using five samples collected between 120 and 240 minutes. Methods Four different combinations of shorter sampling strategies were investigated. Performance was evaluated using measurements of bias, precision, and accuracy (P2, P5, and mean absolute error). Results The mean R-mGFR of the 43 participants was 102.3±13.7 ml/min per 1.73 m 2 . All shorter mGFRs had biases <1 ml/min per 1.73 m 2 and mean absolute error <1.6 ml/min per 1.73 m 2 . All shorter mGFRs were within 5% of the R-mGFR, and the majority were within 2%. Conclusions These results demonstrate that shortening the mGFR procedure in individuals with preserved GFR provides similar results to the current standard while significantly decreasing procedure time.
No takes yet. Share an insight, caveat, or question.
White et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: